What questions should I ask a patient with an elevated mean corpuscular volume (MCV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What to Ask a Patient with Elevated MCV

When evaluating a patient with elevated MCV (>100 fL), focus your history on alcohol consumption, medication use (especially chemotherapy agents, anticonvulsants, and immunosuppressants), dietary patterns for B12/folate deficiency, and symptoms of underlying liver disease or hypothyroidism. 1, 2

Structured History-Taking Approach

Alcohol and Substance Use

  • Quantify alcohol intake precisely: Ask about daily/weekly consumption in standard drinks. Alcohol is one of the most common causes of macrocytosis in hospitalized patients 3, 4
  • Document lifetime alcohol exposure, as chronic use causes macrocytosis even without current consumption 5

Medication History

Critical medications that cause macrocytosis:

  • Chemotherapy agents: hydroxyurea, diphenytoin 1
  • Immunosuppressants: azathioprine, 6-mercaptopurine (thiopurines) 2
  • Anticonvulsants: phenytoin 1
  • Antiretrovirals and other drugs 2

Ask specifically about these medications, as drug therapy is the leading cause of macrocytosis 3

Nutritional and Gastrointestinal History

  • Dietary patterns: Strict vegetarian/vegan diet (B12 deficiency risk) 2
  • Malabsorption symptoms: Chronic diarrhea, steatorrhea
  • Surgical history: Gastric surgery, ileal resection, extensive small bowel disease (impairs B12/folate absorption) 2
  • Gastrointestinal symptoms: Blood in stool, changes in bowel habits 1

Symptoms of Specific Deficiencies

For B12 deficiency (especially if MCV >120 fL):

  • Neurologic symptoms: paresthesias, numbness, gait disturbance, cognitive changes 1
  • Glossitis, angular cheilitis
  • Note: MCV >120 fL is usually caused by B12 deficiency 1, 3

For folate deficiency:

  • Similar to B12 but typically without neurologic manifestations 1, 2

Systemic Disease Indicators

  • Liver disease symptoms: Jaundice, right upper quadrant pain, ascites 1, 5
  • Hypothyroidism: Fatigue, cold intolerance, weight gain, constipation 2
  • Hemolysis indicators: Dark urine, jaundice, splenomegaly 2

Hematologic Disease History

  • Prior blood disorders or malignancies
  • Family history of blood disorders
  • Symptoms suggesting myelodysplastic syndrome: unexplained cytopenias, recurrent infections, easy bruising 1

Key Clinical Pitfalls

Important caveats:

  • MCV can be falsely normal when microcytosis (iron deficiency) and macrocytosis (B12/folate deficiency) coexist—check RDW (red cell distribution width), which will be elevated 2
  • Megaloblastic changes may not be visible on peripheral smear in early disease—only 30% show classic megaloblastic erythropoiesis 4
  • Reticulocytosis itself causes macrocytosis—if reticulocyte count is elevated, consider hemolysis or acute blood loss rather than nutritional deficiency 2
  • MCV sensitivity for B12 deficiency is poor: Only 17-30% sensitive in screening populations, up to 77% in pernicious anemia 6. An elevated MCV justifies B12 testing, but normal MCV does not exclude deficiency

Immediate Laboratory Follow-up

After history, order:

  • Reticulocyte count (distinguishes production vs. destruction) 1, 2
  • Peripheral blood smear (macro-ovalocytes, hypersegmented neutrophils suggest megaloblastic anemia) 1, 3
  • Vitamin B12 and folate levels 1, 2
  • Liver function tests 2, 3
  • TSH (hypothyroidism) 2
  • Methylmalonic acid and homocysteine if B12 deficiency suspected but serum B12 borderline 1, 3

The history should systematically exclude the most common causes: drugs, alcohol, liver disease, and reticulocytosis account for >90% of macrocytosis cases, with megaloblastic anemia (B12/folate deficiency) representing <10% 3, 4.

References

Guideline

cancer- and chemotherapy-induced anemia.

Journal of the National Comprehensive Cancer Network : JNCCN, 2012

Research

Etiology and diagnostic evaluation of macrocytosis.

The American journal of the medical sciences, 2000

Research

The clinical significance of macrocytosis.

Acta medica Scandinavica, 1981

Research

Diagnostic value of the mean corpuscular volume in the detection of vitamin B12 deficiency.

Scandinavian journal of clinical and laboratory investigation, 2000

Related Questions

How should I evaluate and manage an adult with an elevated mean corpuscular volume (MCV)?
What is the significance of an elevated mean corpuscular volume (MCV 107.6 fL) with a normal mean corpuscular hemoglobin (MCH 33 pg) and otherwise normal labs, and what work‑up should be done?
What is the clinical significance of a high mean corpuscular volume (MCV)?
What does the mean corpuscular volume (MCV) indicate, what is its normal range, and how are abnormal values evaluated and managed?
Why does my mean corpuscular volume (MCV) remain near 100 fL after over a year of blood donations (about five donations) instead of decreasing?
What anticholinergic medications for overactive bladder have the least central nervous system effects?
What analgesic and treatment options are appropriate for severe degenerative joint disease (osteoarthritis) in a patient with chronic kidney disease stage 3?
How many nephrons are present in each kidney?
Why is the free thyroxine low in a patient taking levothyroxine 137 µg, with an elevated free triiodothyronine on liothyronine 50 µg and a suppressed thyroid‑stimulating hormone?
Given a patient who is heterozygous for MTHFR C677T, heterozygous for ADRA2A -1291G>C, HTR2A G/G, SLC6A4 L/S, a CYP2D6 *4/*41 poor metabolizer, CYP1A2 -163A/A (highly inducible), and extensive metabolizer for CES1A1, CYP2B6, CYP2C19, CYP2C9, CYP3A4, UGT1A4, and UGT2B15, what pharmacogenetic‑guided medication plan—including ADHD and depression treatment, folate supplementation, and dermatologic risk considerations—should be recommended?
How should a 69-year-old man with left facial (mouth and lip) numbness and left hand weakness be evaluated and managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.